Notice
지속가능한 성장과 투명한 경영으로
신뢰를 만들어갑니다.
지속가능한 성장과 투명한 경영으로
신뢰를 만들어갑니다.
Notice

주식회사 프록시헬스케어 ㅣ 대표자 : 김영욱
울산광역시 울주군 청량읍 처용산업3길 135,
울산 자유무역지역 경공업2동 3층, 서편
대표전화 : 070-4124-8734
메일 : office@proxihealthcare.com
사업자번호 : 136-88-01475
개인정보보호책임자 : 김영욱
주식회사 프록시헬스케어 ㅣ 대표자 : 김영욱
울산광역시 울주군 청량읍 처용산업3길 135, 울산 자유무역지역 경공업2동 3층, 서편
대표전화 : 070-4124-8734 ㅣ 메일 : office@proxihealthcare.com
사업자번호 : 136-88-01475 ㅣ 개인정보보호책임자 : 김정교
COPYRIGHT ProxiHealthcare Inc. ALL RIGHTS RESERVED
University of Maryland, College Park, MD, USA
2017. 11. 17
A long-term, interdisciplinary research collaboration at the University of Maryland’s A. James Clark School of Engineering has made significant progress in detecting and treating bacterial biofilms by developing new chemical compounds, materials, and microsystems that can fight these sources of post-operative infections.
In their 10-year collaboration, Professor Reza Ghodssi (Department of Electrical and Computer Engineering; Institute for Systems Research), Professor William Bentley (Fischell Department of Bioengineering; Robert E. Fischell Institute for Biomedical Devices), and their students and colleagues have advanced the state of the art in both biofilm detection and treatment. They have developed microsystems that can detect and measure biofilm as well as microsystems for biofilm treatment. The most recent device, which can be placed in urinary catheters, can do all three.
자세히 보기 〉